Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Anabolic effects and safety assessments of TH9507, a growth hormone releasing factor (GRF) analog, in patients with COPD-associated wasting Source: Eur Respir J 2004; 24: Suppl. 48, 292s Year: 2004
Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Prevalence of subnormal adrenal responses to low dose synthetic ACTH (synacthen) in children receiving ≥ 500 mcg daily of the inhaled steroid fluticasone propionate (FP) Source: Eur Respir J 2003; 22: Suppl. 45, 310s Year: 2003
Salivary cortisol for assessment of hypothalamic-pituitary-adrenal (HPA) axis function in asthmatic children on inhaled corticosteroids (ICS) Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Utility of salivary cortisol in corticotropin releasing hormone (CRH) test in asthmatics Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
A low-dose (1.0 mcg) rapid ACTH test and adrenal function in adult patients with bronchial asthma treated with inhaled corticosteroids Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007
Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA) Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007
Prognostic value of cortisol and adrenocorticotropic hormone (ACTH) in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
One year vitamin D and parathyroid hormone influence in patients with OSAS and CPAP treatment Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018
Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response to low-dose ACTH test Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids Source: Eur Respir J 2006; 27: 511-516 Year: 2006
Anti-inflammatory effect of montelukast (ML) and inhaled steroids (ICS) on clinical parameters and serum levels of NO in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003
Combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) versus similar ICS dose in children and adults with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 124s Year: 2005
Real-life use and impact of inhaled steroids (ICS) and leukotriene receptor antagonists (LTRA) monotherapy in children with asthma Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids Source: Eur Respir J 2008; 32: 1047-1052 Year: 2008
Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019
First choice in persistent asthma: inhaled corticosteroids (ICS) or ICS + long-acting beta2-agonist (LABA) combination in steroid-naïve patients? Source: Annual Congress 2004 - Further pharmacological and clinical evidence for using long-acting β-agonists with inhaled corticosteroids Year: 2004
Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination vs. high doses of ICS: efficacy and safety in patients (pts) with uncontrolled occupational asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017